The April 2026 issue (Volume 2, Number 4) of the IJPHARMDART [eISSN: 3139-1117] has been officially published, presenting an insightful collection of scholarly articles that address emerging challenges and innovations in pharmaceutical sciences, biomedical research, and environmental health. This edition reflects the journal's continued commitment to disseminating evidence-based scientific knowledge that contributes to healthcare advancement and sustainable development.
The issue features three peer-reviewed review articles authored by distinguished researchers Sagar Sahu, Sonam Sahu, and Gunjan Kalyani, whose work explores contemporary developments ranging from forest conservation and neurodegenerative disease therapeutics to biologics and biosimilars in the Indian healthcare landscape.
Forests as the Foundation of Future Medicines
Leading the issue is the thought-provoking review, "Forests Are Nature's Pharmacy: To Conserve Them Is To Replenish Our Supply," authored by Sagar Sahu and Gunjan Kalyani. The article emphasizes the indispensable role of forests as reservoirs of medicinal biodiversity and natural bioactive compounds that have historically served as the foundation for numerous pharmaceutical discoveries.
The authors highlight how accelerating deforestation, habitat degradation, and climate change threaten the availability of valuable medicinal plant species and future drug development. By integrating ecological conservation with pharmaceutical research, the review advocates for sustainable forest management as a strategic investment in global public health, biodiversity preservation, and future therapeutic innovation.
PD-1 Inhibitors: A Novel Direction in Parkinson's Disease Research
Another significant contribution, "PD-1 Inhibitors in Parkinson's Disease: Restoring Dopaminergic Balance," explores an emerging frontier in neuroimmunology. Authored by Sagar Sahu, Sonam Sahu, and Gunjan Kalyani, the review examines the potential application of Programmed Death-1 (PD-1) immune checkpoint inhibitors beyond oncology.
The article discusses recent scientific evidence suggesting that immune modulation may influence neuroinflammation and neuronal survival, offering promising therapeutic possibilities for restoring dopaminergic function in Parkinson's disease. By examining evolving molecular mechanisms and translational research, the authors present a comprehensive overview of how immunotherapy may reshape future treatment paradigms for neurodegenerative disorders.
Advancing India's Biologics and Biosimilars Ecosystem
Completing the issue is the comprehensive review titled "Biologics and Biosimilars: Current Perspective with Reference to India." The article provides an in-depth assessment of the rapidly expanding biologics and biosimilars sector, with particular emphasis on India's regulatory framework, manufacturing capabilities, market opportunities, and healthcare implications.
The authors evaluate current developments in biosimilar approval pathways, affordability, quality assurance, and patient accessibility while highlighting India's growing role as a global manufacturing hub for biologic medicines. The review underscores the importance of strengthening regulatory harmonization, pharmacovigilance systems, and innovation-driven research to ensure sustainable growth within the biopharmaceutical industry.
Promoting Scientific Excellence Through Scholarly Communication
The April 2026 issue exemplifies PharmDart Journal's dedication to publishing multidisciplinary research that bridges environmental science, pharmaceutical innovation, biotechnology, and clinical medicine. Collectively, the featured articles reinforce the importance of collaborative scientific inquiry in addressing contemporary healthcare challenges while promoting sustainable and evidence-based solutions.
As healthcare systems continue to evolve in response to emerging diseases, environmental pressures, and technological advancements, the journal remains committed to providing researchers, academicians, healthcare professionals, and policymakers with high-quality scientific literature that supports informed decision-making and fosters global research collaboration.
Issue Details - https://pharmdart.org/archives-details.php?fldPathId=49
- Journal: PharmDart Journal
- Volume: 2
- Issue: 4
- Publication Month: April 2026
- Publication Date: 30 April 2026
The editorial board congratulates the contributing authors for their valuable scholarly contributions and extends its appreciation to reviewers and readers whose continued support strengthens the journal's mission of advancing pharmaceutical education, research excellence, and scientific innovation.
.png)
0 Comments
Your comments add value to the news!!